UK Value Stocks Priced Below Estimated Worth In September 2026
In recent weeks, the United Kingdom's FTSE 100 index has faced downward pressure due to weak trade data from China, impacting companies with significant exposure to global markets. As the market grapples with these challenges, investors may find opportunities in undervalued stocks that are priced below their estimated worth, offering potential for growth despite broader economic uncertainties.
Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Victorian Plumbing Group (AIM:VIC) | £0.72 | £1.36 | 47% |
| Playtech (LSE:PTEC) | £4.00 | £7.59 | 47.3% |
| M&G (LSE:MNG) | £3.431 | £6.31 | 45.6% |
| Kistos Holdings (AIM:KIST) | £2.94 | £5.39 | 45.5% |
| Genuit Group (LSE:GEN) | £2.626 | £4.90 | 46.4% |
| Eurocell (LSE:ECEL) | £1.235 | £2.28 | 45.9% |
| Entain (LSE:ENT) | £5.176 | £10.01 | 48.3% |
| Diaceutics (AIM:DXRX) | £1.465 | £2.86 | 48.8% |
| Convatec Group (LSE:CTEC) | £2.336 | £4.28 | 45.4% |
| Advanced Medical Solutions Group (AIM:AMS) | £2.81 | £5.11 | 45.1% |
Let's uncover some gems from our specialized screener.
Kistos Holdings (AIM:KIST)
Overview: Kistos Holdings Plc is engaged in the development and production of gas and other hydrocarbon reserves in the United Kingdom, Norway, and the Netherlands, with a market capitalization of £244.37 million.
Operations: The company's revenue primarily comes from its Oil & Gas - Exploration & Production segment, generating $212.94 million.
Estimated Discount To Fair Value: 45.5%
Kistos Holdings, trading at £2.94, is significantly undervalued relative to its estimated future cash flow value of £5.39. Analysts forecast the company will become profitable within three years, with earnings expected to grow annually by 16.97%. Despite revenue growth projections of 15% per year being slower than 20%, it surpasses the UK market average of 3.8%. Recent production guidance was maintained at 19,000-21,000 boepd for FY26 after reporting H1 production of 20,500 boepd.
- According our earnings growth report, there's an indication that Kistos Holdings might be ready to expand.
- Take a closer look at Kistos Holdings' balance sheet health here in our report.
Convatec Group (LSE:CTEC)
Overview: Convatec Group PLC develops, manufactures, and sells medical products, services, and technologies for managing chronic conditions across Europe, North America, and internationally with a market cap of £4.57 billion.
Operations: The company's revenue segment focuses on the development, manufacture, and sale of medical products and technologies, generating $2.49 billion.
Estimated Discount To Fair Value: 45.4%
Convatec Group, trading at £2.34, is significantly undervalued with an estimated future cash flow value of £4.28. Despite a high debt level and lower net profit margins compared to last year, earnings are forecasted to grow significantly over the next three years at 25.9% annually, outpacing the UK market's average growth rate of 11.5%. The company initiated a $200 million share buyback program in August 2026 to optimize capital structure and enhance shareholder value.
- In light of our recent growth report, it seems possible that Convatec Group's financial performance will exceed current levels.
- Click here and access our complete balance sheet health report to understand the dynamics of Convatec Group.
Marshalls (LSE:MSLH)
Overview: Marshalls plc, with a market cap of £400.88 million, manufactures and sells landscape, building, and roofing products in the United Kingdom and internationally.
Operations: The company's revenue segments include £193.70 million from roofing products, £171.20 million from building products, and £265.50 million from landscaping products.
Estimated Discount To Fair Value: 44.6%
Marshalls plc, trading at £1.59, is highly undervalued compared to its future cash flow value of £2.86, offering a potential opportunity for investors focused on cash flow valuation. Despite being dropped from major indices like FTSE 250 and FTSE 350 in June 2026, its earnings are forecasted to grow significantly at 27.2% annually over the next three years, surpassing the UK market average growth rate of 11.5%. Recent interim dividend increases further reflect financial stability amidst fluctuating revenue figures.
- The growth report we've compiled suggests that Marshalls' future prospects could be on the up.
- Click here to discover the nuances of Marshalls with our detailed financial health report.
Key Takeaways
- Discover the full array of 50 Undervalued UK Stocks Based On Cash Flows right here.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com